Biotie Therapies - Company Announcement

Organization of the Board of Directors and Board committees

BIOTIE THERAPIES CORP.      STOCK EXCHANGE RELEASE        29 May 2015 at 8.45
a.m.

Organization of the Board of Directors and Board committees

As announced by Biotie Therapies Corp. (the "Company" or "Biotie") on 29 May
2015, Biotie has completed the issuance of in total 220,400,001 convertible
promissory notes and 220,400,001 warrants to certain US investors and certain
existing shareholders. Consequently, in accordance with the resolution of the
Annual General Meeting of the Company on 26 May 2015, the terms of Don M. Bailey
and Mahendra G. Shah as members of Biotie's Board of Directors commence and the
number of Board members increases from five (5) to seven (7).

Following the addition of new Board members, the Board of Directors has
determined the composition of its committees. Don M. Bailey was elected the
Chairman and Bernd Kastler and Merja Karhapää the members of the Board's Audit
Committee. Furthermore, William Burns was elected the Chairman and Guido Magni,
Ismail Kola and Mahendra G. Shah the members of the Nomination and Remuneration
Committee.

The Board of Directors has also elected Bernd Kastler as the Vice Chairman of
the Board.

Turku, 29 May 2015

Biotie Therapies Corp.

Timo Veromaa
President and CEO

For further information, please contact:

David Cook, CFO
Tel. +358 2 2748 900, e-mail: david.cook@biotie.com

DISTRIBUTION:

NASDAQ OMX Helsinki Ltd
Main Media

www.biotie.com


[HUG#1924865]